IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$1.00
52W Range
$0.48 - $1.66
50D Avg
$0.98
200D Avg
$1.10
Market Cap
$68.21M
Avg Vol (3M)
$1.65M
Beta
2.48
Div Yield
-
ICCM Company Profile
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.